Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 5/2017

01-05-2017 | Original Article

Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area

Authors: Y.-Y. Chen, J.-Y. Feng, W.-Y. Ting, Y.-F. Yen, P.-H. Chuang, S.-W. Pan, V. Y.-F. Su, W.-J. Su

Published in: Osteoporosis International | Issue 5/2017

Login to get access

Abstract

Summary

The occurrence of osteoporosis in tuberculosis, a chronic infection, has rarely been evaluated. In this study, we found significantly higher incidence rates of osteoporosis (Adjusted hazard ratio (AHR) 1.82) and osteoporotic fracture (AHR 2.33) in tuberculosis patients than matched cohorts, which suggest that osteoporosis screening should be considered in tuberculosis patients’ follow-up program. The aim of this study is to determine the occurrence of incident osteoporosis in patients who completed anti-tuberculosis (TB) treatment.

Introduction

Chronic inflammatory disorders are associated with an increased risk of osteoporosis. Although TB is an infectious disease characterized by systemic inflammatory responses, the impact of active TB on incident osteoporosis is unclear. We used the Taiwan National Health Insurance Research Database to investigate the association between history of active TB and incident osteoporosis and osteoporotic fracture.

Methods

In this nationwide retrospective cohort study, active TB patients and their age- and sex-matched controls were identified from the National Health Insurance Research Database in Taiwan during 2000–2012. The occurrence of incident osteoporosis, osteoporotic fractures, and risk factors associated with osteoporosis among TB patients and matched controls were analyzed.

Results

We observed incident osteoporosis in 2.2% (n = 86) of the TB patients and in 1.1% (n = 162) of the matched controls. The incidence rate of osteoporosis was 4.31 and 1.80 per 1000 person-years, which was significantly higher in TB patients (p < 0.001). In multivariate analysis, TB was an independent risk factor for osteoporosis. The other independent factors associated with osteoporosis were older age, female sex, chronic obstructive pulmonary disease, asthma, and lower income. Moreover, we demonstrated that the occurrence of osteoporotic fracture was significantly higher in TB patients.

Conclusions

Patients with a history of active TB have a higher incidence rate of osteoporosis and osteoporotic fracture.
Literature
1.
2.
3.
4.
Kethireddy S, Light RB, Mirzanejad Y et al (2013) Mycobacterium tuberculosis septic shock. Chest 144(2):474–482CrossRefPubMed
5.
Shame M, Tabarsi P, Pohjan S et al (2011) Tuberculosis-associated secondary pneumothorax: a retrospective study of 53 patients. Respir Care 56(3):298–302CrossRef
6.
Jordan TS, Spencer EM, Davies P (2010) Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology 15(4):623–628CrossRefPubMed
7.
Kuo SC, Hu YW, Liu CJ et al (2013) Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study. Br J Cancer 109(1):229–234CrossRefPubMedPubMedCentral
8.
9.
10.
11.
Hofbauer LC, Kholsa S, Dustan CR, Lacey DL, Boyle WJ, Riggs BL (2000) The role of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15(1):2–12CrossRefPubMed
12.
Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65(12 Pt 2):147–151CrossRef
13.
Redlich K, Smolen JS (2012) Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 11(3):234–250CrossRefPubMed
14.
Kaufmann SH, Dorhoi A (2013) Inflammation in tuberculosis: interactions, imbalances and interventions. Curr Opin Immuno 25(4):441–449CrossRef
15.
Wu CY, Chen YJ, Ho HJ et al (2012) Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 308(18):1906–1914CrossRefPubMed
16.
Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20(3):236–242CrossRefPubMed
17.
Fan WC, Liu CJ, Hong YC et al (2015) Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study. Int J Tuberc Lung Dis 19(1):58–64CrossRefPubMed
18.
Yang NP, Deng CY, Chou YJ et al (2006) Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy 75(3):329–337CrossRefPubMed
19.
Lai SW, Liao KF, Lai HC et al (2013) Risk of major osteoporotic fracture after cardiovascular disease: a population-based cohort study in Taiwan. J Epidemiol 23(2):109–114CrossRefPubMedPubMedCentral
20.
Hsiao PC, Chen TJ, Li CY et al (2015) Risk factors and incidence of repeat osteoporotic fractures among the elderly in Taiwan: a population-based cohort study. Medicine(Baltimore) 94(7):E532
21.
van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787CrossRefPubMed
22.
Graat-Verboom L, Wouters EFM, Smeenk FWJM, van den Borne BEEM, Lunde R, Spruit MA (2009) Current status of research on osteoporosis in COPD: a systemic review. Eur Respir J 34(1):209–218CrossRefPubMed
23.
Inoue D, Watanabe R, Okazaki R (2016) COPD and osteoporosis: links, risks, and treatment challenges. Int J Chro Obstruct Pulmon Dis 11:637–648CrossRef
24.
Chen SJ, Liao WC, Huang KH et al (2015) Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fracture: a population-based cohort study. QJM 108(8):633–640CrossRefPubMed
25.
Dam TT, Harrison S, Fink HA, Ramsdell J, Barette-Conner E, Osteoporotic Fractures in Men Research Group (2010) Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int 21(8):1341–1349CrossRefPubMed
26.
Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309(5):265–268CrossRefPubMed
27.
Melton LJ 3rd, Patel A, Achenbach SJ, Oberg AL, Yunginger JW (2004) Long-term fracture risk following adult-onset asthma: a population-based study. Osteoporos Int 15(4):311–316CrossRefPubMed
28.
29.
Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292(4):490–495CrossRefPubMed
30.
31.
Reddy MS, Morgan SL (2013) Decreased bone mineral density and periodontal management. Periodontol 2000 61(1):195–218CrossRefPubMed
32.
Moonga BS, Adebanjo OA, Wang HJ et al (2002) Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts. J Endocrionol 173(3):395–405CrossRef
33.
Kim JH, Jin HM, Kim K et al (2009) The mechanism of osteoclast differentiation induced by IL-1. J Immunol 183(3):1862–1870CrossRefPubMed
34.
Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S (1999) Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25(3):255–259CrossRefPubMed
35.
Lim LS, Hoeksema LJ, Sherin K, Prevention Practice Committee ACPM (2009) Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice. Am J Prev Med 36:366–375CrossRefPubMed
36.
Papaioannou A, Morin S, Cheung AM et al (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182(17):1864–1873CrossRefPubMedPubMedCentral
37.
38.
Feng JY, Su WJ, Chiu YC et al (2011) Initial presentations predict mortality in pulmonary tuberculosis patients— a prospective observational study. PLoS One 6:E23715CrossRefPubMedPubMedCentral
39.
Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO (2009) Pattern and diversity of cytokine production differentiates between mycobacterium tuberculosis infection and disease. Eur J Immunol 39(3):723–729CrossRefPubMed
40.
Deveci F, Akbulut HH, Turgut T, Muz MH (2005) Changes in serum cytokine levels in active tuberculosis with treatment. Mediat Inflamm 5:256–262CrossRef
41.
Su WL, Perng WC, Huang CH, Yang CY, Wu CP, Chen JH (2010) Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis. Clin Vaccine Immunol 17(2):223–231CrossRefPubMed
42.
Chung WS, Lin CL, Hung CT et al (2014) Tuberculosis increases the subsequent risk of acute coronary syndrome: a nationwide population-based cohort study. Int J Tuberc Lung Dis 18:79–83CrossRefPubMed
43.
Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB (2015) Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis 32:138–146CrossRefPubMed
44.
von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C (2010) Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11(4):344–349CrossRef
45.
Selvaraj P, Afsal K, Harishankar M (2015) Vitamin D and macrophage functions in tuberculosis. Macrophage 2:E756
46.
Nnoaham KE, Clarke A (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37(1):113–119CrossRefPubMed
47.
48.
Sutaria N, Liu CT, Chen TC (2014) Vitamin D status, receptor gene polymorphisms, and supplementation on tuberculosis: a systematic review of case-control studies and randomized controlled trials. J Clin Transl Endocrinol 1(4):151–160CrossRefPubMedPubMedCentral
Metadata
Title
Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area
Authors
Y.-Y. Chen
J.-Y. Feng
W.-Y. Ting
Y.-F. Yen
P.-H. Chuang
S.-W. Pan
V. Y.-F. Su
W.-J. Su
Publication date
01-05-2017
Publisher
Springer London
Published in
Osteoporosis International / Issue 5/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-017-3939-x

Other articles of this Issue 5/2017

Osteoporosis International 5/2017 Go to the issue

Original Article

Effect of comorbidities on the association between age and hospital mortality after fall-related hip fracture in elderly patients

Original Article

Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study

Letter

Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?

Letter

Conclusions stand firm with additional data

Original Article

Use of proton pump inhibitors and mortality after hip fracture in a nationwide study

Review

Worldwide prevalence and incidence of osteoporotic vertebral fractures